Literature DB >> 12851820

Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter.

Hiroko Segawa1, Eri Kawakami, Ichiro Kaneko, Masashi Kuwahata, Mikiko Ito, Kenichiro Kusano, Hitoshi Saito, Naoshi Fukushima, Ken-Ichi Miyamoto.   

Abstract

Fibroblast growth factor 23 (FGF23), a phosphaturic factor, is involved in the regulation of renal inorganic phosphate (Pi) reabsorption. Proteolysis-resistant FGF23 mutants expressed in rodents reduce Pi uptake in both intestine and kidney, independent of parathyroid hormone action. In the present study, we investigated whether FGF23 affects dietary regulation of Na(+)-dependent Pi (Na/Pi) cotransport in the rat kidney using wild-type FGF23 and an R179Q mutant, which disrupts a consensus proteolytic cleavage motif. Rats injected with naked human FGF23 DNA (wild-type or R179Q mutant) expressed the human FGF23 transcript in the liver. In those animals, plasma calcium and parathyroid hormone levels were not affected by FGF23 (either wild-type or R179Q mutant). FGF23-R179Q did, however, significantly decrease plasma Pi and renal Na/Pi cotransport activity and also the level of type-IIc Na/Pi cotransporter protein in brush-border membrane vesicles (BBMVs) from normal rat kidney. Western blot and immunohistochemical analyses in rats fed a low-Pi diet showed the levels of types-IIa and -IIc Na/Pi cotransporters to be markedly increased. After injection of FGF23-R179Q DNA into the rats fed a low-Pi diet, the levels of the types-IIa and -IIc transporter proteins were decreased. The FGF23 mutant thus blunts the signalling of Pi deprivation to the renal type-II Na/Pi cotransporter, suggesting that the FGF23 pathway could be involved in the signalling of dietary Pi.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851820     DOI: 10.1007/s00424-003-1084-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  22 in total

1.  Growth-related renal type II Na/Pi cotransporter.

Authors:  Hiroko Segawa; Ichiro Kaneko; Akira Takahashi; Masashi Kuwahata; Mikiko Ito; Ichiro Ohkido; Sawako Tatsumi; Ken-Ichi Miyamoto
Journal:  J Biol Chem       Date:  2002-03-05       Impact factor: 5.157

2.  Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.

Authors:  K Kruse; D Woelfel; T M Strom; T M Storm
Journal:  Horm Res       Date:  2001

3.  Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry.

Authors:  M Custer; M Lötscher; J Biber; H Murer; B Kaissling
Journal:  Am J Physiol       Date:  1994-05

4.  Effects of dietary Pi on the renal Na+-dependent Pi transporter NaPi-2 in thyroparathyroidectomized rats.

Authors:  F Takahashi; K Morita; K Katai; H Segawa; A Fujioka; T Kouda; S Tatsumi; T Nii; Y Taketani; H Haga; S Hisano; Y Fukui; K I Miyamoto; E Takeda
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

5.  Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production.

Authors:  Hitoshi Saito; Kenichiro Kusano; Masahiko Kinosaki; Hirotaka Ito; Michinori Hirata; Hiroko Segawa; Ken-Ichi Miyamoto; Naoshi Fukushima
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

6.  Regulation of type II renal Na+-dependent inorganic phosphate transporters by 1,25-dihydroxyvitamin D3. Identification of a vitamin D-responsive element in the human NAPi-3 gene.

Authors:  Y Taketani; H Segawa; M Chikamori; K Morita; K Tanaka; S Kido; H Yamamoto; Y Iemori; S Tatsumi; N Tsugawa; T Okano; T Kobayashi; K Miyamoto; E Takeda
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

7.  Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury.

Authors:  H Tanaka; K I Miyamoto; K Morita; H Haga; H Segawa; T Shiraga; A Fujioka; T Kouda; Y Taketani; S Hisano; Y Fukui; K Kitagawa; E Takeda
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

8.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 9.  Molecular characteristics of phosphate transporters and their regulation.

Authors:  N Hernando; I C Forster; J Biber; H Murer
Journal:  Exp Nephrol       Date:  2000 Nov-Dec

10.  Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine.

Authors:  H Hilfiker; O Hattenhauer; M Traebert; I Forster; H Murer; J Biber
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more
  40 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

4.  Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.

Authors:  Anders Nordholm; Maria L Mace; Eva Gravesen; Jacob Hofman-Bang; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

5.  Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.

Authors:  Takashi Shimada; Itaru Urakawa; Tamara Isakova; Yuji Yamazaki; Michael Epstein; Katherine Wesseling-Perry; Myles Wolf; Isidro B Salusky; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

6.  Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.

Authors:  Regina Goetz; Yuji Nakada; Ming Chang Hu; Hiroshi Kurosu; Lei Wang; Teruyo Nakatani; Mingjun Shi; Anna V Eliseenkova; Mohammed S Razzaque; Orson W Moe; Makoto Kuro-o; Moosa Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

7.  FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

Authors:  Jyothsna Gattineni; Carlton Bates; Katherine Twombley; Vangipuram Dwarakanath; Michael L Robinson; Regina Goetz; Moosa Mohammadi; Michel Baum
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10

8.  NHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilli.

Authors:  Hector Giral; DeeAnn Cranston; Luca Lanzano; Yupanqui Caldas; Eileen Sutherland; Joanna Rachelson; Evgenia Dobrinskikh; Edward J Weinman; R Brian Doctor; Enrico Gratton; Moshe Levi
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

9.  Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation.

Authors:  Miwa Yamazaki; Masanobu Kawai; Kazuaki Miyagawa; Yasuhisa Ohata; Kanako Tachikawa; Saori Kinoshita; Jin Nishino; Keiichi Ozono; Toshimi Michigami
Journal:  J Bone Miner Metab       Date:  2014-07-05       Impact factor: 2.626

Review 10.  Overview of the FGF23-Klotho axis.

Authors:  Makoto Kuro-o
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.